CRISPR Therapeutics laid off a number of employees a week after FDA advisers all but greenlighted the company’s Vertex-partnered, CRISPR-edited sickle cell therapy, sources told Fierce Biotech.
https://www.fiercebiotech.com/biotech/crispr-therapeutics-laid-number-employees-week-after-positive-adcomm